Cardio-Oncology

BMC

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cardio-Oncology is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,490 EUR. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
BMC
ISSN
2057-3804
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,490 EUR
Articles in DOAJ
498
Declared review time
7 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2017-12-06
  • PUBMED · 2015-11-26
Indexing
DOAJ · PUBMED
APC
2,490 EUR
Declared review time (DOAJ)
7 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

498

Most recent article

last month

Average review time (journal-declared via DOAJ)

7weeks

Works in OpenAlex

556

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

32

i10-index

121

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2017-12-06
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
LOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
88%
ORCID iDs in current deposits
14%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101689938
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) systemMedicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC666-701RC254-282

Subject areas

  • Chemotherapy-induced cardiotoxicity and mitigation
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
Show all subjects (50)
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Function and Risk Factors
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cardiac tumors and thrombi
  • Cardiac tumors and thrombi
  • Cancer-related cognitive impairment studies
  • Cancer-related cognitive impairment studies
  • Pericarditis and Cardiac Tamponade
  • Pericarditis and Cardiac Tamponade
  • Acute Myocardial Infarction Research
  • Cancer, Lipids, and Metabolism
  • Acute Myocardial Infarction Research
  • Cancer, Lipids, and Metabolism
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Heart Failure Treatment and Management
  • Chemotherapy-induced organ toxicity mitigation
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Chemotherapy-induced organ toxicity mitigation
  • Heart Failure Treatment and Management
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Cardiac electrophysiology and arrhythmias
  • Cancer Risks and Factors
  • Inflammatory Biomarkers in Disease Prognosis
  • Cardiac electrophysiology and arrhythmias
  • Advanced Breast Cancer Therapies
  • Childhood Cancer Survivors' Quality of Life
  • Effects of Radiation Exposure
  • Cancer Risks and Factors
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Inflammatory Biomarkers in Disease Prognosis
  • Childhood Cancer Survivors' Quality of Life
  • Venous Thromboembolism Diagnosis and Management
  • Metabolism, Diabetes, and Cancer

Keywords (DOAJ)

  • cardiology
  • oncology
  • cardiotoxicity
  • chemotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: